The DOI matches its Crossref record; 444 of the 444 references it cites were found in a registry or an index.
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
Open accessAbstract
The insulin receptor (IR) gene undergoes differential splicing that generates two IR isoforms, IR-A and IR-B. The physiological roles of IR isoforms are incompletely understood and appear to be determined by their different binding affinities for insulin-like growth factors (IGFs), particularly for IGF-2. Predominant roles of IR-A in prenatal growth and development and of IR-B in metabolic regulation are well established. However, emerging evidence indicates that the differential expression of IR isoforms may also help explain the diversification of insulin and IGF signaling and actions in various organs and tissues by involving not only different ligand-binding affinities but also different membrane partitioning and trafficking and possibly different abilities to interact with a variety of molecular partners. Of note, dysregulation of the IR-A/IR-B ratio is associated with insulin resistance, aging, and increased proliferative activity of normal and neoplastic tissues and appears to sustain detrimental effects. This review discusses novel information that has generated remarkable progress in our understanding of the physiology of IR isoforms and their role in disease. We also focus on novel IR ligands and modulators that should now be considered as an important strategy for better and safer treatment of diabetes and cancer and possibly other IR-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 401–444 of 444
Engineering of Insulin Receptor Isoform-Selective Insulin Analogues
Glendorf, T., Stidsen, C. E., Norrman, M., Nishimura, E., Sørensen, A. R., & Kjeldsen, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020288 · Cited by 26
Plasma Distribution and Signaling Activities of IGF-II Precursors
Marks, A. G., Carroll, J. M., Purnell, J. Q., & Roberts, C. T. (2011) · Endocrinology · doi:10.1210/en.2010-0784 · Cited by 26
Hashimoto, R., Sakai, K., Matsumoto, H., & Iwashita, M. (2010) · Endocrine Journal · doi:10.1507/endocrj.k09e-189 · Cited by 26
Elevated C-peptide and insulin predict increased risk of colorectal adenomas in normal mucosa
Vidal, A. C., Lund, P. K., Hoyo, C., Galanko, J. A., Burcal, L., Holston, R., Massa, B., Omofoye, O. A., Sandler, R. S., & Keku, T. O. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-389 · Cited by 26
Hepatocyte Growth Factor and Clinical Diabetes in Postmenopausal Women
Rajpathak, S. N., Wassertheil-Smoller, S. W., Crandall, J. P., Liu, S., & Ho, G. (2010) · Diabetes Care · doi:10.2337/dc10-0710 · Cited by 24
Issafras, H., Bedinger, D., Corbin, J., Goldfine, I. D., Bhaskar, V., White, M., Rubin, P. D., & Scannon, P. J. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814529886 · Cited by 24
Impacts of Alternative Splicing Events on the Differentiation of Adipocytes
Lin, J.-C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922169 · Cited by 24
Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor B
Giudice, J., Barcos, L. S., Guaimas, F. F., Steinhardt, A. P., Giordano, L., Jares-Erijman, E. A., & Leskow, F. C. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-18 · Cited by 24
Díaz-Castroverde, S., Baos, S., Luque, M., Scala, M. D., González‐Aseguinolaza, G., Gómez‐Hernández, A., Beneit, N., Escribano, Ó., & Benito, M. (2016) · Diabetologia · doi:10.1007/s00125-016-4088-z · Cited by 24
Basak, A., Chen, A., Scamuffa, N., et al. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791331040 · Cited by 23
Insulin receptor isoform A ameliorates long-term glucose intolerance in diabetic mice
Díaz-Castroverde, S., Gómez‐Hernández, A., Fernández, S., García-Gómez, G., Scala, M. D., González‐Aseguinolaza, G., Fernández‐Millán, E., González‐Rodríguez, Á., García-Bravo, M., Chambon, P., et al. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.025288 · Cited by 23
Gletsu-Miller, N. A., Field, C. J., & Clandinin, M. T. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00043-5 · Cited by 22
Basal insulin analogs: From pathophysiology to therapy. What we see, know, and try to comprehend?
Monnier, L., Colette, C., & Owens, D. R. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.09.003 · Cited by 22
Prolonged tyrosine kinase activation of insulin receptor by pY27-caveolin-2
Kwon, H., & Pak, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.159 · Cited by 22
Insulin–InsR signaling drives multipotent progenitor differentiation toward lymphoid lineages
Xia, P., Wang, S., Du, Y., Huang, G., Satoh, T., Akira, S., & Fan, Z. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150618 · Cited by 22
Bonnesen, C., Holm, G. N., Hansen, B. F., Jensen, P., Krabbe, J. S., Jensen, M. B., Hegelund, A. C., Svendsen, J. E., & Oleksiewicz, M. B. (2009) · Cell Biology and Toxicology · doi:10.1007/s10565-009-9142-x · Cited by 21
Corbin, J., Bhaskar, V., Goldfine, I. D., Bedinger, D., Lau, A., Michelson, K. S., Gross, L. M., Maddux, B. A., Kuan, H. F., Tran, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088684 · Cited by 21
Sanderson, M. P., Apgar, J. F., Garin‐Chesa, P., Hofmann, M. H., Kessler, D., Quant, J., Savchenko, A., Schaaf, O., Treu, M., Tye, H., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0539 · Cited by 21
Rational steering of insulin binding specificity by intra-chain chemical crosslinking
Viková, J., Collinsová, M., Kletvíková, E., Buděšı́nský, M., Kaplan, V., Žáková, L., Veverka, V., Hexnerova, R., Aviñó, R. J. T., Straková, J., et al. (2016) · Scientific Reports · doi:10.1038/srep19431 · Cited by 21
Schwartz, G. K., Dickson, M. A., LoRusso, P. M., Sausville, E. A., Maekawa, Y., Watanabe, Y., Kashima, N., Nakashima, D., & Akinaga, S. (2016) · Cancer Science · doi:10.1111/cas.12906 · Cited by 21
Wei, Y., Gokhale, R. H., Sonnenschein, A., Montgomery, K. M., Ingersoll, A. J., & Arnosti, D. N. (2016) · Development · doi:10.1242/dev.138073 · Cited by 21
Henderson, S. T., Brierley, G. V., Surinya, K. H., Priebe, I. K., Catcheside, D., Wallace, J. C., Forbes, B. E., & Cosgrove, L. J. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.09.004 · Cited by 20
Insulin Analogs and Cancer: A Note of Caution
Janssen, J. A. M. J. L., & Varewijck, A. J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00079 · Cited by 20
Wang, H., Ge, S., Qian, G., Li, W., Cui, J., Wang, G., Hoffman, A. R., & Hu, J. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.09.016 · Cited by 20
Arnoldo, L., Sgarra, R., CHIEFARI, E. D., Iiritano, S., Arcidiacono, B., Pegoraro, S., Pellarin, I., Brunetti, A., & Manfioletti, G. (2015) · Scientific Reports · doi:10.1038/srep08552 · Cited by 19
Non-small cell lung cancer cell survival crucially depends on functional insulin receptors
Frisch, C. M., Zimmermann, K., Zilleßen, P., Pfeifer, A., Racké, K., & Mayer, P. E. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0581 · Cited by 19
ter Braak, B., Siezen, C. L. E., Kannegieter, N. M., Koedoot, E., van de Water, B., & van der Laan, J. W. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1201-2 · Cited by 18
Santoro, M. A., Andres, S. F., Galanko, J. A., Sandler, R. S., Keku, T. O., & Lund, P. K. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0177 · Cited by 18
Baričević-Jones, I., Jones, D. R., Roberts, D. L., Lützen, A., Lundby, A., Worm, J., Hansen, B. F., & Renehan, A. G. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv071 · Cited by 18
Unusual Forms Of Insulin Resistance
Taylor, S. I., Accili, D., Cama, A., Imano, E., Kadowaki, H., & Kadowaki, T. (1991) · Annual Review of Medicine · doi:10.1146/annurev.me.42.020191.002105 · Cited by 18
Multiple roles of RBM4 in muscle cell differentiation
Lin, J.-C. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/260 · Cited by 17
Lundby, A., Bolvig, P. U., Hegelund, A. C., Hansen, B. F., Worm, J., Lützen, A., Billestrup, N., Bonnesen, C., & Oleksiewicz, M. B. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.3082 · Cited by 16
Zhang, G., Li, X., Zhang, L., et al. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.04.007 · Cited by 15
Yoshizato, K., Shirotani, T., Furukawa, N., Taguchi, T., Motoshima, H., Toyonaga, T., Hirashima, Y., Kawashima, J., Ebina, Y., Shichiri, M., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4140 · Cited by 15
Bezwada, P., Zhao, J., Der, K., Shimizu, B., Cao, L., Ahene, A. B., Rubin, P. D., & Johnson, K. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.229690 · Cited by 14
Nolan, C. J., & Delghingaro‐Augusto, V. (2016) · Diabetes · doi:10.2337/dbi15-0020 · Cited by 13
Timing‐Dependent Modulation of Insulin Mitogenic Versus Metabolic Signalling
MEYTS, P. D., & Shymko, R. M. (2000) · Novartis Foundation symposium · doi:10.1002/0470870796.ch4 · Cited by 12
Phylogenetic and Molecular Characterization of the Splicing Factor RBM4
Lu, C., Chen, T.-H., Wu, J.-R., Chen, H.-H., Yu, H.-Y., & Tarn, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059092 · Cited by 12
ter Braak, B., Wink, S., Koedoot, E., Pont, C., Siezen, C. L. E., van der Laan, J. W., & van de Water, B. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0600-5 · Cited by 9
Age-related changes in insulin receptor mRNA and protein expression in genetically obese Zucker rats
Amessou, M., Tahiri, K., Chauvet, G., & Desbuquois, B. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.09.004 · Cited by 9
Scotlandi, K., & Belfiore, A. (2012) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2012.32.134 · Cited by 8
Self-citationInsulin receptor membrane retention by a traceable chimeric mutant
Giudice, J., Jares-Erijman, E. A., & Leskow, F. C. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-45 · Cited by 7
Martínez‐Campos, E., Hernández‐SanMiguel, E., López‐Sánchez, C., de Pablo, F., & Hernández‐Sánchez, C. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.05.060 · Cited by 6
Insulin Effects on Survival of Human Multiple Myeloma Cells
Сакенович, Ш. С., Кравцова, Т. А., Chernykh, Y. B., & Cheikina, N. N. (2015) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-015-2937-2 · Cited by 3
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
ImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
Hyperinsulinemia in Obesity, Inflammation, and Cancer
Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0250 · Cited by 305
Insulin-like growth factors: Ligands, binding proteins, and receptors
LeRoith, D., Holly, J. M. P., & Forbes, B. E. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101245 · Cited by 303
Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance
Rhea, E. M., & Banks, W. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00521 · Cited by 263
Metadata
- Authors
- Belfiore, A., Malaguarnera, R., Vella, V., Lawrence, M. C., Sciacca, L., Frasca, F., Morrione, A., & Vigneri, R.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2017-06-19
- Volume
- 38
- Issue
- 5
- Pages
- 379-431
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2715761994
- Cited by
- 375
- References
- 444
- FWCI
- 20.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.